Connection

Robert Stuart to NF-kappa B

Back to Details
This is a "connection" page, showing publications Robert Stuart has written about NF-kappa B.
Robert Stuart
Connection Strength
0.020
NF-kappa B
  1. A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias. Clin Cancer Res. 2011 Mar 01; 17(5):1140-6.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.